The Impact of RADIANT: A Deep Dive into the Study

https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/07/59/8b/07598b02-138a-1e92-767a-a6ad123b0f45/mza_3116404523087549397.jpg/600x600bb.jpg

Diabetes Discourse

ReachMD

202 episodes

1 month ago

As the number of Americans living with diabetes continues to rise, staying up to date on the latest diabetes research is more essential than ever to help patients achieve glucose control. With Diabetes Discourse, you’ll hear from diabetes and endocrinology experts on emerging research, diagnostic and treatment strategies, and various elements that impact a patient’s disease course, including risk factors, vitamin and mineral supplementation, physical activity, and kidney disease. Because when it comes to diabetes, glucose control is just the beginning.

Science

Medicine

RSS

All content for Diabetes Discourse is the property of ReachMD and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Science

Medicine

The Impact of RADIANT: A Deep Dive into the Study

Diabetes Discourse

2 years ago

The Impact of RADIANT: A Deep Dive into the Study

Host: John Buse, MD, PhD
Guest: Louis Philipson, MD, PhD

Over the last 15 years, the monogenic diabetes registry now has over 4,000 patients involved, and from that, the RADIANT study was started to identify new kinds of rare and atypical diabetes. So how can genetics testing and the RADIANT study provide atypical diabetes patients with better diagnoses and treatment? Learn more with Dr. John Buse and Dr. Louis Philipson, Professor in the Department of Medicine and Pediatrics at the University of Chicago.